Algert Global LLC Cardiovascular Systems Inc Transaction History

Algert Global LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$13.31 - $19.86 $1.27 Million - $1.89 Million	-95,107 Reduced 84.95%	16,844 $335,000
Q4 2022 Feb 13, 2023	SELL	$12.74 - $15.12 $293,529 - $348,364	-23,040 Reduced 17.07%	111,951 $1.53 Million
Q3 2022 Nov 15, 2022	BUY	$12.93 - $17.17 $198,695 - $263,851	15,367 Added 12.85%	134,991 $1.87 Million
Q2 2022 Aug 15, 2022	BUY	$13.53 - $23.34 $172,507 - $297,585	12,750 Added 11.93%	119,624 $1.72 Million
Q1 2022 May 16, 2022	BUY	$16.14 - $22.6 $745,910 - $1.04 Million	46,215 Added 76.19%	106,874 $2.42 Million
Q4 2021 Feb 14, 2022	BUY	$18.64 - $36.77 $230,390 - $454,477	12,360 Added 25.59%	60,659 $1.14 Million
Q3 2021 Nov 15, 2021	BUY	$32.83 - $43.0 $1.11 Million - $1.45 Million	33,779 Added 232.64%	48,299 $1.59 Million
Q2 2021 Aug 13, 2021	BUY	$34.41 - $44.03 $112,520 - $143,978	3,270 Added 29.07%	14,520 $619,000
Q1 2021 May 14, 2021	BUY	$37.29 - $47.19 $419,512 - $530,887	11,250 New	11,250 $431,000

35.5K

Ticker CSII
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 41,905,900
Description
Cardiovascular Systems, Inc., a medical technology company, develops and commercializes solutions to treat peripheral and coronary artery diseases in the United States and internationally. The company offers peripheral artery disease products comprising catheter-based platforms to treat various plaque types in above and below the knee, including...

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

Stay updated on Algert Global LLC with notifications on news.